Skip to main content

Table 2 Growth characteristics per MNV type

From: The long-term effects of anti-vascular endothelial growth factor therapy on the optical coherence tomography angiographic appearance of neovascularization in age-related macular degeneration

 

Type 1

Type 2

Type 3

p

MNV area, mm2

 Baseline

3.4 ± 3.26

2.84 ± 2.28

0.34 ± 0.53

0.019*

 Endpoint

3.28 ± 3.46

2.96 ± 1.98

0.35 ± 0.28

0.04*

MNV vessel density, mm2/mm2

 Baseline

0.35 ± 0.21

0.53 ± 0.72

0.35 ± 0.28

0.715

 Endpoint

0.37 ± 0.18

0.61 ± 0.33

0.59 ± 0.2

0.05*

 Growth rate, %/year (n)

7.17 ± 53.03 (21)

28.51 ± 50.27 (10)

− 62.923 ± 19.97 (3)

0.01*

 % shrink (n)

42.86% (9)

30% (3)

100% (3)

0.099

 % stable (n)

28.57% (6)

20% (2)

0.525

 % grow (n)

28.57% (6)

50% (5)

0.224

  1. *p ≤ 0.05